Skip to main content
Erschienen in:

01.01.2018 | Original Research Article

Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees

verfasst von: Christos A. Grigoras, Styliani Karanika, Elpida Velmahos, Michail Alevizakos, Myrto-Eleni Flokas, Christos Kaspiris-Rousellis, Ioannis-Nektarios Evaggelidis, Panagiotis Artelaris, Constantinos I. Siettos, Eleftherios Mylonakis

Erschienen in: Drugs | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The opioid epidemic is an escalating health crisis. We evaluated the impact of opioid prescription rates and socioeconomic determinants on opioid mortality rates, and identified potential differences in prescription patterns by categories of practitioners.

Methods

We combined the 2013 and 2014 Medicare Part D data and quantified the opioid prescription rate in a county level cross-sectional study with data from 2710 counties, 468,614 unique prescribers and 46,665,037 beneficiaries. We used the CDC WONDER database to obtain opioid-related mortality data. Socioeconomic characteristics for each county were acquired from the US Census Bureau.

Results

The average national opioid prescription rate was 3.86 claims per beneficiary that received a prescription for opioids (95% CI 3.86–3.86). At a county level, overall opioid prescription rates (p < 0.001, Coeff = 0.27) and especially those provided by emergency medicine (p < 0.001, Coeff = 0.21), family medicine physicians (p = 0.11, Coeff = 0.008), internal medicine (p = 0.018, Coeff = 0.1) and physician assistants (p = 0.021, Coeff = 0.08) were associated with opioid-related mortality. Demographic factors, such as proportion of white (p white < 0.001, Coeff = 0.22), black (p black < 0.001, Coeff = − 0.19) and male population (p male < 0.001, Coeff = 0.13) were associated with opioid prescription rates, while poverty (p < 0.001, Coeff = 0.41) and proportion of white population (p white < 0.001, Coeff = 0.27) were risk factors for opioid-related mortality (p model < 0.001, R 2 = 0.35). Notably, the impact of prescribers in the upper quartile was associated with opioid mortality (p < 0.001, Coeff = 0.14) and was twice that of the remaining 75% of prescribers together (p < 0.001, Coeff = 0.07) (p model = 0.03, R 2 = 0.03).

Conclusions

The prescription opioid rate, and especially that by certain categories of prescribers, correlated with opioid-related mortality. Interventions should prioritize providers that have a disproportionate impact and those that care for populations with socioeconomic factors that place them at higher risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52.CrossRefPubMed Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–52.CrossRefPubMed
5.
Zurück zum Zitat Hawton K, Bergen H, Simkin S, Wells C, Kapur N, Gunnell D. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study. PLoS Med. 2012;9(5):e1001213.CrossRefPubMedPubMedCentral Hawton K, Bergen H, Simkin S, Wells C, Kapur N, Gunnell D. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study. PLoS Med. 2012;9(5):e1001213.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes—Florida, 2010–2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):569–74.PubMed Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes—Florida, 2010–2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):569–74.PubMed
7.
Zurück zum Zitat Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, et al. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag J Can Pain Soc. 2014;19(4):179–85.CrossRef Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, et al. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag J Can Pain Soc. 2014;19(4):179–85.CrossRef
8.
Zurück zum Zitat Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of medicare prescribers. JAMA Int Med. 2016;176(2):259–61.CrossRef Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of opioids by different types of medicare prescribers. JAMA Int Med. 2016;176(2):259–61.CrossRef
14.
Zurück zum Zitat Belsley DA, Kuh E, Welsch RE. Detecting and assessing collinearity. Regression diagnostics. Hoboken: John Wiley & Sons, Inc.; 2005. p. 85–191. Belsley DA, Kuh E, Welsch RE. Detecting and assessing collinearity. Regression diagnostics. Hoboken: John Wiley & Sons, Inc.; 2005. p. 85–191.
17.
Zurück zum Zitat Olsen Y. The CDC guideline on opioid prescribing: rising to the challenge. JAMA. 2016;315(15):1577–9.CrossRefPubMed Olsen Y. The CDC guideline on opioid prescribing: rising to the challenge. JAMA. 2016;315(15):1577–9.CrossRefPubMed
18.
Zurück zum Zitat Goldenbaum DM, Christopher M, Gallagher RM, Fishman S, Payne R, Joranson D, et al. Physicians charged with opioid analgesic-prescribing offenses. Pain Med (Malden, Mass.). 2008;9(6):737–47.CrossRef Goldenbaum DM, Christopher M, Gallagher RM, Fishman S, Payne R, Joranson D, et al. Physicians charged with opioid analgesic-prescribing offenses. Pain Med (Malden, Mass.). 2008;9(6):737–47.CrossRef
19.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDc guideline for prescribing opioids for chronic pain—united states, 2016. JAMA. 2016;315(15):1624–45.CrossRefPubMed Dowell D, Haegerich TM, Chou R. CDc guideline for prescribing opioids for chronic pain—united states, 2016. JAMA. 2016;315(15):1624–45.CrossRefPubMed
20.
Zurück zum Zitat Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2016;65(1):1–49. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2016;65(1):1–49.
22.
Zurück zum Zitat Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663–73.CrossRefPubMedPubMedCentral Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663–73.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011;9(3):219–25.CrossRefPubMedPubMedCentral Becker WC, Starrels JL, Heo M, Li X, Weiner MG, Turner BJ. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med. 2011;9(3):219–25.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Cerda M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, et al. Prescription opioid mortality trends in New York City, 1990–2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132(1–2):53–62.CrossRefPubMedPubMedCentral Cerda M, Ransome Y, Keyes KM, Koenen KC, Tracy M, Tardiff KJ, et al. Prescription opioid mortality trends in New York City, 1990–2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013;132(1–2):53–62.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Mack KA, Zhang K, Paulozzi L, Jones C. Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved. 2015;26(1):182–98.CrossRefPubMedPubMedCentral Mack KA, Zhang K, Paulozzi L, Jones C. Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved. 2015;26(1):182–98.CrossRefPubMedPubMedCentral
Metadaten
Titel
Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees
verfasst von
Christos A. Grigoras
Styliani Karanika
Elpida Velmahos
Michail Alevizakos
Myrto-Eleni Flokas
Christos Kaspiris-Rousellis
Ioannis-Nektarios Evaggelidis
Panagiotis Artelaris
Constantinos I. Siettos
Eleftherios Mylonakis
Publikationsdatum
01.01.2018
Verlag
Springer International Publishing
Erschienen in
Drugs / Ausgabe 1/2018
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI
https://doi.org/10.1007/s40265-017-0846-6